<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: HISTORY AND ADMISSION FINDINGs: A 61-year-old woman was found unconscious by her husband </plain></SENT>
<SENT sid="1" pm="."><plain>The emergency doctor detected <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> (blood <z:chebi fb="105" ids="17234">glucose</z:chebi> 1.7 mmol/l) </plain></SENT>
<SENT sid="2" pm="."><plain>This was the first such event, the patient had not been known to have <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>At admission the physical examination and the laboratory findings revealed no abnormalities </plain></SENT>
<SENT sid="4" pm="."><plain>INVESTIGATIONS: A fasting test was aborted shortly after the start because of the <z:hpo ids='HP_0003674'>onset</z:hpo> of neurological symptoms </plain></SENT>
<SENT sid="5" pm="."><plain>An <z:e sem="disease" ids="C0021670" disease_type="Neoplastic Process" abbrv="">insulinoma</z:e> was excluded by detecting suppressed levels of insulin and C-<z:chebi fb="7" ids="16670">peptide</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Computed tomography of the abdomen revealed a mesenteric <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> of 9 cm in diameter, which was identified immunhistologically as a grade 1 follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL).  After exclusion of endocrinological causes the recurrent <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> was diagnozed as part of a <z:e sem="disease" ids="C0030472" disease_type="Neoplastic Process" abbrv="">paraneoplastic syndrome</z:e> associated with a non-<z:e sem="disease" ids="C0242363" disease_type="Neoplastic Process" abbrv="">islet cell tumour</z:e> <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> (NICTH) with a newly diagnosed FL </plain></SENT>
<SENT sid="7" pm="."><plain>TREATMENT AND COURSE: Specific medication with the CD20 antibody rituximab (375 mg/m2, once per week for a total of four cycles) was initiated </plain></SENT>
<SENT sid="8" pm="."><plain>There were no further episodes of <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>After one year the patient remains free of any symptoms </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: After exclusion of any endocrinological reasons for <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo>, differential diagnosis should include NICTH as <z:e sem="disease" ids="C0030472" disease_type="Neoplastic Process" abbrv="">paraneoplastic syndrome</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>In rare cases a <z:e sem="disease" ids="C0848852,C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancy</z:e> may be the underlying disease </plain></SENT>
<SENT sid="12" pm="."><plain>The specific treatment of this disease likewise represents the causal treatment of NICTH </plain></SENT>
</text></document>